Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Uppsala Clinical Pharmaceutics AB
AB
Active
Org 5591962328
Österängsgatan 8 A, 753 27
Uppsala
Activities of performing arts
· NACE 9020
Est. 2019
0 employees
Watchlist
Share
Sweden
/
Companies
/
Activities of performing arts
/
Uppsala Clinical Pharmaceutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
39
40
167
130
82
Staff expenses
—
−3
−0
−0
−0
EBITDA
9
13
117
93
33
Depreciation & amort.
−0
—
—
—
—
EBIT
9
13
117
93
33
Net financials
—
−0
0
0
−0
Profit before tax
9
13
117
93
32
Tax
−2
−3
−24
−19
−7
Net profit
7
10
93
74
25
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
123
128
247
316
330
Equity
118
128
221
295
320
Long-term debt
0
—
—
—
—
Short-term debt
5
0
26
20
9
Total debt
5
—
26
20
9
Financial ratios
5-year trend
EBITDA margin
39.8%
This company
15.8%
Market median
+152% vs market
2021
2025
Equity ratio
97.3%
This company
38.2%
Market median
+155% vs market
2021
2025
Return on equity
7.8%
This company
18.4%
Market median
-58% vs market
2021
2025
Net profit margin
30.7%
This company
8.1%
Market median
+279% vs market
2021
2025
Asset turnover
0.25×
This company
1.12×
Market median
-78% vs market
2021
2025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Uppsala Clinical Pharmaceutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network